Inactivation of human serum plasminogen antiactivator by synthetic fibrinolysis inducers.
D000818:Animals; D000933:Antifibrinolytic Agents; D000941:Antigens; D001241:Aspirin / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001779:Blood Coagulation Factors / Q000032:analysis; D011232:Chemical Precipitation; D002845:Chromatography; D003911:Dextrans; D005342:Fibrinolysis / Q000187:drug effects; D005439:Flufenamic Acid / Q000494:pharmacology; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D008074:Lipoproteins; D008259:Macroglobulins; D010958:Plasminogen; D000644:Quaternary Ammonium Compounds; D011817:Rabbits; D012459:Salicylates / Q000494:pharmacology
D000933:Antifibrinolytic Agents; D000941:Antigens; D001565:Benzoates; D001779:Blood Coagulation Factors; D003911:Dextrans; D007106:Immune Sera; D008074:Lipoproteins; D008259:Macroglobulins; D000644:Quaternary Ammonium Compounds; D012459:Salicylates; D005439:Flufenamic Acid; D010958:Plasminogen; D001241:Aspirin